Standard Chemical & Pharmaceutical Co. Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 1,645.53 million compared to TWD 1,549.87 million a year ago. Net income was TWD 223.88 million compared to TWD 238.6 million a year ago. Basic earnings per share from continuing operations was TWD 1.25 compared to TWD 1.34 a year ago. Diluted earnings per share from continuing operations was TWD 1.25 compared to TWD 1.33 a year ago.
For the nine months, sales was TWD 4,647.56 million compared to TWD 4,268.1 million a year ago. Net income was TWD 673.18 million compared to TWD 640.51 million a year ago. Basic earnings per share from continuing operations was TWD 3.77 compared to TWD 3.58 a year ago. Diluted earnings per share from continuing operations was TWD 3.76 compared to TWD 3.58 a year ago.